<DOC>
	<DOCNO>NCT02029625</DOCNO>
	<brief_summary>The purpose study compare pharmacokinetics NVP-1205 coadministration rosuvastatin ezetimibe .</brief_summary>
	<brief_title>Compare Pharmacokinetics NVP-1205 Coadministration Rosuvastatin Ezetimibe</brief_title>
	<detailed_description>rosuvastatin ezetimibe ( anti-dyslipidemia )</detailed_description>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Healthy male subject age 19 55 sign inform consent subject history allergy reaction drug drug</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>